Ketamine in Bipolar Disorder: A Review

Area of Science:

• Psychiatry
• Neuroscience
• Pharmacology

Background:

• Bipolar disorder (BD) is a severe mental illness with high rates of morbidity, mortality, and suicide.
• BD is characterized by a neuroprogressive course and significant treatment resistance.
• Existing treatment strategies for BD are limited, necessitating novel therapeutic approaches.

Purpose of the Study:

• To investigate the potential of ketamine as a novel treatment for bipolar disorder (BD).
• To provide a novel insight into ketamine's efficacy for BD, building upon its known effects in unipolar depression.

Main Methods:

• Review of existing literature on ketamine's effects in unipolar depression.
• Analysis of pharmacological and neurobiological mechanisms relevant to BD.
• Argumentative synthesis of evidence to support ketamine's potential in BD treatment.

Main Results:

• Ketamine demonstrates rapid antidepressant and antisuicidal effects.
• Most current research on ketamine focuses on unipolar depression, leaving a gap in BD understanding.
• Ketamine's mechanisms of action may be applicable to the neurobiological underpinnings of BD.

Conclusions:

• Ketamine presents a promising therapeutic avenue for bipolar disorder (BD).
• Further research is warranted to establish ketamine's safety and efficacy in treating BD.
• Novel treatment strategies like ketamine are crucial for addressing the unmet needs in BD management.